AVANCES EN DIAGNÓSTICO TEMPRANO DE CÁNCER TESTICULAR: INTEGRACIÓN DE BIOMARCADORES Y TÉCNICAS DE IMAGEN
Palabras clave:
Cáncer testicular, Diagnóstico temprano, Biomarcadores, Técnicas de imagenResumen
El diagnóstico preciso del cáncer testicular (CT), una neoplasia común en hombres jóvenes, se está transformando mediante la integración de biomarcadores séricos y técnicas avanzadas de imagen. El objetivo principal de esta revisión bibliográfica es analizar los avances en el diagnóstico temprano del CT mediante la integración de biomarcadores séricos y técnicas de imagen, buscando identificar su impacto en la precisión diagnóstica y la detección precoz. La metodología consistió en una revisión bibliográfica de alto impacto utilizando bases de datos como PubMed y ScienceDirect, enfocada en la integración de biomarcadores y técnicas de imagen para el diagnóstico de cáncer testicular, y aplicando estrictos criterios de inclusión y exclusión de la literatura.
Descargas
Citas
Referencias Bibliográficas
Pang KH, Alnajjar HM, Muneer A. Diagnosis, Treatment and Survival From Testicular Cancer: Real-World Data From the National Health Service England Between 2013 and 2020. Clin Genitourin Cancer [Internet]. 2025 Aug 1 [cited 2025 Nov 5];23(4):102367. Available from: https://www.sciencedirect.com/science/article/pii/S1558767325000680
Bainomugisa CK, Dasgupta P, Cameron JK, Tran B, Cramb SM, Baade PD. Spatial patterns of testicular cancer diagnosis in Australia, 2010-2019. Spat Spatiotemporal Epidemiol [Internet]. 2025 Nov 1 [cited 2025 Nov 5];55:100745. Available from: https://www.sciencedirect.com/science/article/pii/S187758452500036X
Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, et al. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Annals of Oncology [Internet]. 2018 Aug 1 [cited 2025 Nov 5];29(8):1658–86. Available from: https://www.sciencedirect.com/science/article/pii/S092375341934133X
Mehr FK, Emtiazi N, Zolfi E. Advances in cell therapy for testicular cancer: a comprehensive overview of immunotherapy and stem cell therapy. Tissue Cell [Internet]. 2026 Feb 1 [cited 2025 Nov 5];98:103169. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0040816625004513
Thomas KL, Jeong D, Montilla-Soler J, Feuerlein S. The role of diagnostic imaging in the primary testicular cancer: initial staging, response assessment and surveillance. Transl Androl Urol [Internet]. 2020 Jan 1 [cited 2025 Nov 5];9(Suppl 1):S3–13. Available from: https://tau.amegroups.org/article/view/27358/html
Lobo J, Acosta AM, Netto GJ. Molecular Biomarkers With Potential Clinical Application in Testicular Cancer. Modern Pathology [Internet]. 2023 Oct 1 [cited 2025 Nov 5];36(10):100307. Available from: https://www.sciencedirect.com/science/article/pii/S0893395223002120
Ujfaludi Z, Fazekas F, Biró K, Oláh-Németh O, Buzogany I, Sükösd F, et al. miR-21, miR-29a, and miR-106b: serum and tissue biomarkers with diagnostic potential in metastatic testicular cancer. Scientific Reports 2024 14:1 [Internet]. 2024 Aug 30 [cited 2025 Nov 5];14(1):1–12. Available from: https://www.nature.com/articles/s41598-024-70552-x
Ditonno F, Franco A, Manfredi C, Fasanella D, Abate M, La Rocca R, et al. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives. Medicina 2023, Vol 59, Page 2033 [Internet]. 2023 Nov 17 [cited 2025 Nov 5];59(11):2033. Available from: https://www.mdpi.com/1648-9144/59/11/2033/htm
Sykes J, Kaldany A, Jang TL. Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell Tumors. Journal of Clinical Medicine 2024, Vol 13, Page 7448 [Internet]. 2024 Dec 6 [cited 2025 Nov 5];13(23):7448. Available from: https://www.mdpi.com/2077-0383/13/23/7448/htm
Malik MMUD, Alqahtani MM, Hadadi I, Kanbayti I, Alawaji Z, Aloufi BA. Molecular Imaging Biomarkers for Early Cancer Detection: A Systematic Review of Emerging Technologies and Clinical Applications. Diagnostics [Internet]. 2024 Nov 1 [cited 2025 Nov 5];14(21):2459. Available from: https://www.mdpi.com/2075-4418/14/21/2459/htm
Egan J, Salari K. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond. Urologic Clinics of North America [Internet]. 2023 Feb 1 [cited 2025 Nov 5];50(1):133–43. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0094014322000623
Feng Z, Wu J, Lu Y, Chan YT, Zhang C, Wang D, et al. Circulating tumor cells in the early detection of human cancers. Int J Biol Sci [Internet]. 2022 [cited 2025 Nov 5];18(8):3251–65. Available from: https://www.ijbs.com://creativecommons.org/licenses/by/4.0/
Milardi D, Grande G, Vincenzoni F, Pierconti F, Pontecorvi A. Proteomics for the identification of biomarkers in testicular cancer–review. Front Endocrinol (Lausanne) [Internet]. 2019 Jul 12 [cited 2025 Nov 5];10(JULY):457412. Available from: www.frontiersin.org
Ghosh S, Rajendran RL, Mahajan AA, Chowdhury A, Bera A, Guha S, et al. Harnessing exosomes as cancer biomarkers in clinical oncology. Cancer Cell International 2024 24:1 [Internet]. 2024 Aug 7 [cited 2025 Nov 5];24(1):1–26. Available from: https://cancerci.biomedcentral.com/articles/10.1186/s12935-024-03464-5
Wang YT, Shi T, Srivastava S, Kagan J, Liu T, Rodland KD. Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer. Cancers 2020, Vol 12, Page 2335 [Internet]. 2020 Aug 19 [cited 2025 Nov 5];12(9):2335. Available from: https://www.mdpi.com/2072-6694/12/9/2335/htm
Salciccia S, Capriotti AL, Laganà A, Fais S, Logozzi M, De Berardinis E, et al. Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes. International Journal of Molecular Sciences 2021, Vol 22, Page 4367 [Internet]. 2021 Apr 22 [cited 2025 Nov 5];22(9):4367. Available from: https://www.mdpi.com/1422-0067/22/9/4367/htm
Fontoura RN, Santos NB dos, Franchini MSDB, Lima FF, Junior AOM, Boden RT, et al. Screening pediatric testicular cancer: A literature review. Archives of Community Medicine and Public Health [Internet]. 2022 Jul 28 [cited 2025 Nov 5];8(3):099–102. Available from: https://www.healthdisgroup.com/articles/ACMPH-8-281.php
Pierorazio PM, Cheaib JG, Tema G, Patel HD, Gupta M, Sharma R, et al. Performance Characteristics of Clinical Staging Modalities for Early Stage Testicular Germ Cell Tumors: A Systematic Review. Journal of Urology [Internet]. 2020 May 1 [cited 2025 Nov 5];203(5):894–901. Available from: /doi/pdf/10.1097/JU.0000000000000594
Altunkurek SZ, Altunkurek SZ. Testicular Cancer and the Importance of Early Diagnosis. Male Reproductive Health [Internet]. 2020 Mar 4 [cited 2025 Nov 5]; Available from: https://www.intechopen.com/chapters/69655
Magbanua MJM, Li W, van ’t Veer LJ. Integrating Imaging and Circulating Tumor DNA Features for Predicting Patient Outcomes. Cancers 2024, Vol 16, Page 1879 [Internet]. 2024 May 15 [cited 2025 Nov 5];16(10):1879. Available from: https://www.mdpi.com/2072-6694/16/10/1879/htm
Stephenson A, Bass EB, Bixler BR, Daneshmand S, Kirkby E, Marianes A, et al. Diagnosis and Treatment of Early-Stage Testicular Cancer: AUA Guideline Amendment 2023. Journal of Urology [Internet]. 2024 Jan 1 [cited 2025 Nov 5];211(1):20–5. Available from: /doi/pdf/10.1097/JU.0000000000003694
De Perrot T, Zoua CS, Glessgen CG, Botsikas D, Berchtold L, Salomir R, et al. Diffusion-Weighted MRI in the Genitourinary System. Journal of Clinical Medicine 2022, Vol 11, Page 1921 [Internet]. 2022 Mar 30 [cited 2025 Nov 8];11(7):1921. Available from: https://www.mdpi.com/2077-0383/11/7/1921/htm
Törzsök P, Deininger S, Abenhardt M, Oswald D, Lusuardi L, Deininger C, et al. Discriminating Malignant from Benign Testicular Masses Using Multiparametric Magnetic Resonance Imaging—A Prospective Single-Center Study. J Clin Med [Internet]. 2024 Aug 1 [cited 2025 Nov 8];13(15):4390. Available from: https://www.mdpi.com/2077-0383/13/15/4390/htm
Jian Y, Yang S, Liu R, Tan X, Zhao Q, Wu J, et al. Radiomics Analysis of Different Machine Learning Models based on Multiparametric MRI to Identify Benign and Malignant Testicular Lesions. Acad Radiol [Internet]. 2025 Jul 1 [cited 2025 Nov 8];32(7):4061–81. Available from: https://www.academicradiology.org/action/showFullText?pii=S1076633225000674
Zafar S, Hafeez A, Shah H, Mutiullah I, Ali A, Khan K, et al. Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. European Journal of Medical Research 2025 30:1 [Internet]. 2025 Aug 18 [cited 2025 Nov 5];30(1):1–34. Available from: https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-025-03003-6
Chuluunbaatar Y, Bansal S, Brodie A, Sharma A, Vasdev N. The current use of artificial intelligence in testicular cancer: a systematic review. Art Int Surg 2023;3:195-206 [Internet]. 2023 Oct 17 [cited 2025 Nov 5];3(4):195–206. Available from: https://www.oaepublish.com/articles/ais.2023.26
Cicatiello AG, Musone M, Imperatore S, Giulioni C, La Rocca R, Cafarelli A, et al. Circulating miRNAs in genitourinary cancer: pioneering advances in early detection and diagnosis. The Journal of Liquid Biopsy [Internet]. 2025 Jun 1 [cited 2025 Nov 5];8:100296. Available from: https://www.sciencedirect.com/science/article/pii/S2950195425000128
Singla N, Bagrodia A, Baraban E, Fankhauser CD, Ged YMA. Testicular Germ Cell Tumors: A Review. JAMA [Internet]. 2025 Mar 4 [cited 2025 Nov 8];333(9):793–803. Available from: https://jamanetwork.com/journals/jama/fullarticle/2829847
Marroncelli N, Ambrosini G, Errico A, Vinco S, Dalla Pozza E, Cogo G, et al. Is Human Chorionic Gonadotropin a Reliable Marker for Testicular Germ Cell Tumor? New Perspectives for a More Accurate Diagnosis. Cancers 2025, Vol 17, Page 2409 [Internet]. 2025 Jul 21 [cited 2025 Nov 8];17(14):2409. Available from: https://www.mdpi.com/2072-6694/17/14/2409/htm
Chavarriaga J, Nappi L, Papachristofilou A, Conduit C, Hamilton RJ. Testicular cancer. The Lancet [Internet]. 2025 Jul 5 [cited 2025 Nov 8];406(10498):76–90. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0140673625004556
Bobrowski A, Anson-Cartwright L, Kuhathaas K, Jiang DM, Chung P, Bedard P, et al. Role of Lactate Dehydrogenase in Identifying Relapse for Patients with Stage i Testicular Cancer on Surveillance. Journal of Urology [Internet]. 2022 Dec 1 [cited 2025 Nov 8];208(6):1250–7. Available from: /doi/pdf/10.1097/JU.0000000000002931
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 JACQUELINE MERA CHICA
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
